The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ERIC 2022 | Genomic tests available to patients with CLL at tertiary hospitals
Lukas Smolej, MD, PhD, Faculty of Medicine and University Hospital, Charles University, Hradec Králové, Czech Republic, highlights genomic tests available to patients with chronic lymphocytic leukemia (CLL) at a tertiary hospital, including tests for IgHV and TP53 mutational status. This interview took place at the 2022 European Research Initiative on CLL (ERIC) Meeting.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
